Semi-quantitative PCR for <i>Shroom3</i>^<i>fl</i> recombination and band quantification with densitometry. by Jennifer L. Carleton (22208916)

Subjects:

Embryonic <i>Shroom3</i>^{<i>Gt</i>/<i>Gt</i>} hearts show left ventricular thinning. by Jennifer L. Carleton (22208916)

Subjects:

Embryonic <i>Shroom3</i>^{<i>Gt</i>/<i>Gt</i>} hearts show abnormal semilunar valves. by Jennifer L. Carleton (22208916)

Subjects:

Adult <i>Shroom3</i>^<i>+</i>^<i>/Gt</i> mouse hearts show left ventricular thinning. by Jennifer L. Carleton (22208916)

Subjects:

Clinical characteristics of the study population. by Hun Gi Lee (21526538)

“…This before-and-after study investigated the impact of this policy on pedestrian TA (P-TA) patients. …”

Distinct and shared gene expression patterns among leukemia cell lines following EF-24 treatment. by Ajeet P. Singh (22298432)

Subjects:

EF-24 treatment induces distinct gene expression changes in Kasumi-1 cells. by Ajeet P. Singh (22298432)

Subjects:

EF-24 treatment alters gene expression profiles in HL-60 cells. by Ajeet P. Singh (22298432)

Subjects:

Expression analysis of downstream target genes in the IL-10 signaling pathway across myeloid leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

EF-24 treatment modulates gene expression in THP-1 cells. by Ajeet P. Singh (22298432)

Subjects:

Expression analysis of downstream target genes in the p38/MAPK signaling pathway across myeloid leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

EF-24 treatment disrupts key molecular pathways associated with cell survival, proliferation, and viability. by Ajeet P. Singh (22298432)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

Subjects:

The global prevalence of gynecological diseases among women aged 15-49 years in 1990 and 2021, along with the trends and changes observed between these years. by Xiaofeng He (2618752)

Subjects:

Subgroup analysis of AIP and depression. by Siyi Deng (12887198)

“…When AIP > 0.60, premenopausal women had an increased risk of depression, while postmenopausal women had a decreased risk of depression.</p><p>Conclusions</p><p>This study demonstrates that elevated AIP levels are significantly associated with an increased risk of depression in both premenopausal and postmenopausal women. …”